The transition from childhood to adulthood: Managing those with growth hormone deficiency

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 163-175

  Gleeson, Helena ^a   Clayton, Peter E ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858271804     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101814     Document Type: Chapter

References (25)

1. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M: Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005; 152: 165-170.
2. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT, Heaney RP: Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-section-al model. J Clin Invest 1994; 93: 799-808.
3. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM: Reference data for bone density and body composition measured with dual energy X-ray absorptiometry in white children and young adults. Arch Dis Child 2002; 87: 341-347; discussion 341-347.
4. Gordon CL, Halton JM, Atkinson SA, Webber CE: The contributions of growth and puberty to peak bone mass. Growth Dev Aging 1991; 55: 257-262.
5. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP: The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 2003; 88: 1658-1663.
6. de Boer H, Blok GJ, Van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16: 63-86.
7. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM: Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997; 82: 2423-2428.
8. Johannsson G, Albertsson-Wikland K, Bengtsson BA: Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999; 84: 4516-4524.
9. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF, Shalet SM: Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 2002; 87: 3368-3372.
10. Leger J, Danner S, Simon D, Garel C, Czernichow P: Do all patients with childhoodonset growth hormone deficiency (GHD) and ectopic neurohy-pophysis have persistent GHD in adult-hood? J Clin Endocrinol Metab 2005; 90: 650-656.
11. Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA: The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985; 60: 513-516.
12. Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R, de Sanctis C, Gargantini L, Gastaldi R, Ghizzoni L, Secco A, Tinelli C, Ghigo E: Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulinlike growth factor-I measurement. Eur J Endocrinol 2005; 152: 589-596.
13. Tauber M, Jouret B, Cartault A, Lounis N, Gayrard M, Marcouyeux C, Pien-kowski C, Oliver I, Moulin P, Otal P, Joffre F, Arnaud C, Rochiccioli P: Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinu-ation and require follow-up. J Clin Endocrinol Metab 2003; 88: 5101-5106.
14. Fors H, Bjarnason R, Wirent L, Alberts-son-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G: Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discon-tinuing growth hormone treatment in adolescents. Clin Endocrinol (Oxf) 2001; 55: 617-624.
15. Hulthen L, Bengtsson BA, Sunnerhagen KS, Hallberg L, Grimby G, Johannsson G: GH is needed for the maturation of muscle mass and strength in adolescents. J Clin Endocrinol Metab 2001; 86: 4765-4770.
16. Norrelund H, Vahl N, Juul A, Moller N, Alberti KG, Skakkebaek NE, Christiansen JS, Jorgensen JO: Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab 2000; 85: 1912-1917.
17. Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE, Christiansen JS: Continuation of growth hormone (GH) re-placement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 2000; 85: 1874-1881.
18. Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hubner C, Savage MO, Monson JP: Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J Clin En-docrinol Metab 2004; 89: 3890-3895.
19. Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B: Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adult-hood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 2005; 90: 3946-3955.
20. Colao A, Di Somma C, Salerno M, Spi-nelli L, Orio F, Lombardi G: The car-diovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 2002; 87: 3650-3655.
21. Colao A, Di Somma C, Rota F, Di Maio S, Salerno M, Klain A, Spiezia S, Lombardi G: Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. J Clin En-docrinol Metab 2005; 90: 2659-2665.
22. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalova J, Moshang T, Blum WF, Chipman JJ, Quigley CA, Attanasio AF: Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab 2003; 88: 4124-4129.
23. Underwood LE, Attie KM, Baptista J: Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. J Clin Endocrinol Metab 2003; 88: 5273-5280.
24. Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM: Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. J Clin Endocrinol Metab 2004; 89: 4857-4862.
25. Attanasio AF, Shavrikova EP, Blum WF, Shalet SM: Quality of life in child-hood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endo-crinol Metab 2005; 90: 4525-4529.